# The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)

> **NCT05922995** · EARLY_PHASE1 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 20 (actual)

## Conditions studied

- REM Behavior Disorder

## Interventions

- **DRUG:** Tasimelteon

## Key facts

- **NCT ID:** NCT05922995
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-09-30
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Study will not longer be done. Terminated due to sponsor noncompliance.
- **Last updated:** 2025-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05922995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05922995, "The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05922995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*